Michael Vangsted Jensen - Net Worth and Insider Trading

Michael Vangsted Jensen Net Worth

The estimated net worth of Michael Vangsted Jensen is at least $24,885 dollars as of 2023-03-30. Michael Vangsted Jensen is the CFO of Synlogic Inc and owns about 39,500 shares of Synlogic Inc (SYBX) stock worth over $24,885. Details can be seen in Michael Vangsted Jensen's Latest Holdings Summary section.

Transaction Summary of Michael Vangsted Jensen

To

Michael Vangsted Jensen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Vangsted Jensen owns 1 companies in total, including Synlogic Inc (SYBX) .

Click here to see the complete history of Michael Vangsted Jensen’s form 4 insider trades.

Insider Ownership Summary of Michael Vangsted Jensen

Ticker Comapny Transaction Date Type of Owner
SYBX Synlogic Inc 2022-03-03 Chief Financial Officer

Michael Vangsted Jensen Latest Holdings Summary

Michael Vangsted Jensen currently owns a total of 1 stock. Michael Vangsted Jensen owns 39,500 shares of Synlogic Inc (SYBX) as of May 24, 2022, with a value of $24,885.

Latest Holdings of Michael Vangsted Jensen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SYBX Synlogic Inc 2022-05-24 39,500 0.63 24,885

Holding Weightings of Michael Vangsted Jensen


Michael Vangsted Jensen Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Vangsted Jensen has made a total of 1 transactions in Synlogic Inc (SYBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Synlogic Inc is the acquisition of 9,500 shares on May 24, 2022, which cost Michael Vangsted Jensen around $10,640.

Insider Trading History of Michael Vangsted Jensen

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
SYBX
Synlogic Inc
2022-05-24
Buy
9,500.00
31.67%
$1.12
$10,640.00
39,500.00
$0.63
-43.75%
2022-05-25
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Vangsted Jensen Trading Performance

GuruFocus tracks the stock performance after each of Michael Vangsted Jensen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Vangsted Jensen is -5.36%. GuruFocus also compares Michael Vangsted Jensen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Vangsted Jensen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Vangsted Jensen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Vangsted Jensen

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 0.89 -5.36 -44.49
Relative Return to S&P 500(%) 1.64 -10.42 -46.67

Michael Vangsted Jensen Ownership Network

Ownership Network List of Michael Vangsted Jensen

No Data

Ownership Network Relation of Michael Vangsted Jensen


Michael Vangsted Jensen Owned Company Details

What does Synlogic Inc do?

Synlogic Inc is a biopharmaceutical company focused on the discovery and development of Synthetic Biotic medicines which are designed to metabolize a toxic substance, compensate for missing or damaged metabolic pathways, or deliver combinations of therapeutic factors. Synthetic Biotic medicines are generated from the company's proprietary drug discovery and development platform, using Synthetic Biology and leveraging a reproducible, modular approach to develop beneficial microbes that perform or deliver critical therapeutic functions. Its key product candidate is SYNB1618, an oral therapy intended for the treatment of PKU, a rare metabolic disease in which an amino acid known as phenylalanine accumulates in the body as a result of genetic defects.

Who are the key executives at Synlogic Inc?

Michael Vangsted Jensen is the Chief Financial Officer of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , See Remarks Gregg Beloff , and Chief Medical Officer Richard J. Riese .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Michael Vangsted Jensen made 1 insider transaction in Synlogic Inc (SYBX) with a net purchase of 9,500. Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 8,894 shares made by Aoife Brennan , a net sale of 2,650 shares made by Antoine Awad ,

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,544 shares of Synlogic Inc (SYBX) were sold and 9,500 shares were bought by its insiders, resulting in a net sale of 2,044 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Synlogic Inc Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Michael Vangsted Jensen Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Vangsted Jensen. You might contact Michael Vangsted Jensen via mailing address: 301 Binney Street, Suite 402, Cambridge Ma 02142.